Founded in 2020 in South Korea and described in the article as Singapore-based, injewelme develops AI and data-driven preventive and personalised healthcare solutions. Its flagship contactless monitoring technology, DeepHealthVision (DHV), uses remote photoplethysmography to analyse over 20 vital health parameters in roughly 30 seconds via a camera. injewelme also builds predictive AI (DeepHealthNet) to analyse personal health data and a Gamified Health Management app aimed at children and adolescents. In real-world pilots with SingHealth Polyclinics and private partners, DHV demonstrated about 95% detection accuracy. The company plans to expand DHV's parameter set (including blood glucose, stress index, fatigue, and hydration) and pursue customer acquisition in Singapore and broader Southeast Asia. Coverage notes potential deployments across healthcare, eldercare, insurance, and workforce safety but does not disclose revenue or other operating metrics.

Total raised

$1M

Funding rounds

1

Latest round

Equity

Latest activity

Apr 2026